Contemporary Practices in Immunotherapy-Guided Management of Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 44
Special Issue Editors
Interests: non-small cell lung carcinoma; immunotherapy
Interests: non-small cell lung carcinoma; immunotherapy
Special Issue Information
Dear Colleagues,
This Special Issue will assemble current evidence and emerging insights on contemporary practices in immunotherapy-guided management of lung cancer. As ICIs are now embedded across perioperative, locally advanced, and metastatic treatment pathways, clinicians are encountering certain practical questions in daily practice. These include identifying which patients are most likely to benefit, recognizing and managing toxicities at an early stage, and determining how best to modify treatment when resistance arises.
We are pleased to invite the submission of studies examining innovative clinical strategies, biomarkers refining patient selection, and evolving paradigms that integrate ICIs into multimodal care. This Special Issue will highlight advances that are shaping personalized, immunologically informed lung cancer treatment in modern clinical practice.
For this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Strategies for managing oligoprogression on ICIs with integrated radiotherapy;
- Evaluating outcomes and optimizing management of ICI-related toxicities;
- Biomarker-driven patient stratification for immunotherapy;
- AI-enabled prediction of immunotherapy response and long-term outcomes in younger patients with lung cancer;
- Approaches to resistance mechanisms and adaptation of ICI-based regimens.
We look forward to receiving your contributions.
Dr. Eleni Karapanagiotou
Dr. Nikolaos Syrigos
Guest Editors
Dr. Umair Mahmood
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- immunotherapy
- oligoprogressive disease
- radiotherapy
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
